Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Condensed Consolidated Statements of Operations [Abstract]
Net sales	$ 151,819,000	$ 161,810,000	$ 488,347,000	$ 486,392,000
Cost of goods sold	130,826,000	129,235,000	410,536,000	394,295,000
Gross profit	20,993,000	32,575,000	77,811,000	92,097,000
Operating expenses:
General and administrative	13,599,000	14,605,000	42,079,000	41,556,000
Sales and marketing	5,634,000	6,274,000	17,242,000	17,162,000
Research and development	2,547,000	2,635,000	8,330,000	7,631,000
Foreign exchange impact of lease liabilities and forward contracts	(4,313,000)	385,000	(2,553,000)	1,769,000
Total operating expenses	17,467,000	23,899,000	65,098,000	68,118,000
Operating income	3,526,000	8,676,000	12,713,000	23,979,000
Interest expense, net	11,471,000	3,949,000	27,675,000	11,510,000
(Loss) income before income tax (benefit) expense	(7,945,000)	4,727,000	(14,962,000)	12,469,000
Income tax (benefit) expense	(8,971,000)	1,588,000	(9,296,000)	4,786,000
Net income (loss)	$ 1,026,000	$ 3,139,000	$ (5,666,000)	$ 7,683,000
Basic net income (loss) per share (in dollars per share)	$ 0.05	$ 0.16	$ (0.29)	$ 0.4
Diluted net income (loss) per share (in dollars per share)	$ 0.05	$ 0.16	$ (0.29)	$ 0.39
Weighted average number of shares outstanding:
Basic (in shares)	19,474,871	19,184,339	19,383,531	19,124,824
Diluted (in shares)	19,634,153	19,544,174	19,383,531	19,604,780